Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Małgorzata Pieścik-Lech is active.

Publication


Featured researches published by Małgorzata Pieścik-Lech.


Alimentary Pharmacology & Therapeutics | 2013

Review article: the management of acute gastroenteritis in children

Małgorzata Pieścik-Lech; Raanan Shamir; Alfredo Guarino; H. Szajewska

In 2008, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society of Paediatric Infectious Disease (ESPID) developed evidence‐based guidelines for the management of acute gastroenteritis (AGE) in children in Europe.


Annals of Nutrition and Metabolism | 2015

Primary Prevention of Celiac Disease: Environmental Factors with a Focus on Early Nutrition.

Anna Chmielewska; Małgorzata Pieścik-Lech; Hania Szajewska; Raanan Shamir

Celiac disease (CD) is a common autoimmune disorder caused by ingestion of gluten. When diagnosed, it should be treated with a lifelong, strict gluten-free diet. Early infant feeding practices have been suggested as a means of preventing CD. In the last few decades, observational data have suggested that breastfeeding, especially at the time of introducing gluten into the infants diet, as well as the time and mode of gluten first being given to a child could prevent or delay the occurrence of CD. As a result, recommendations advised that it is prudent to avoid both early (<4 months) and late (>7 months) introduction of gluten, and to introduce gluten gradually while the infant is still being breastfed, as this may reduce the risk of celiac disease, type 1 diabetes mellitus, and wheat allergy. Recently, the results of two large randomized trials have shown that breastfeeding in general, breastfeeding during gluten introduction, and early or delayed gluten introduction do not influence the total risk of CD in genetically predisposed individuals. Introducing gluten at 4 versus 6 months in very small amounts, or at 6 versus 12 months, resulted in similar rates of CD in these children. Thus, early feeding practices seem to have no impact on the risk of developing CD during childhood. In children without the genetic predisposition, the age and mode of gluten introduction do not influence the risk anyway.


Journal of Pediatric Gastroenterology and Nutrition | 2017

Systematic Review: Early Infant Feeding and the Risk of Type 1 Diabetes.

Małgorzata Pieścik-Lech; Anna Chmielewska; Raanan Shamir; Hania Szajewska

Background: In addition to genetic background, a number of environmental factors have been claimed to influence the development of type 1 diabetes (T1D), including infant diet. Objective: The aim of the study was to systematically update evidence on the possible relation between early feeding practices and the risk of T1D. Methods: The Cochrane Library, MEDLINE, EMBASE, Web of Science, and CINAHL were searched for studies of any design up to July 2015. MEDLINE and EMBASE were additionally searched in March 2016. The primary outcome measures were the development of T1D or T1D-associated autoimmunity (T1DA). Results: Nine publications were identified. Breastfeeding at the time of gluten introduction, as compared to gluten introduction after weaning, did not reduce the risk of developing T1DA or T1D. In children at high risk of developing T1D, except for gluten introduction at 3 months or younger age compared with gluten introduction at older than 3 months, which increased the risk of T1DA, the age of gluten introduction in infants had no effect on the risk of developing T1DA. Conclusions: Current evidence, mainly from observational studies, does not support the claim that early infant feeding practices, such as breastfeeding at gluten introduction or the age of the infant at the time of gluten introduction, may decrease the risk of developing T1D. More robust data are needed from randomized controlled trials.


Beneficial Microbes | 2017

To add or not to add probiotics to infant formulae? An updated systematic review

Agata Skórka; Małgorzata Pieścik-Lech; Maciej Kołodziej; H. Szajewska

We updated evidence on the effects of the administration of probiotic-supplemented infant formulae (IF) compared with unsupplemented IF. Five databases were searched up to September 2016 for randomised controlled trials. Twenty publications were identified, including five new RCTs. Supplementation of IF with Bifidobacterium lactis Bb12, either alone or with Streptococcus thermophilus, had no effect on growth, respiratory illness, antibiotic use, stool frequency or consistency. However, there was a significant reduction in the number of episodes of gastrointestinal infections (Bb12) and a lower frequency of colic or irritability (when both strains were used). Lactobacillus johnsonii La1 had no effect on growth, gastrointestinal infections, or respiratory illness episodes. There were no effects of supplementation of IF with Bifidobacterium longum BL999, alone or with Lactobacillus rhamnosus LPR. L. rhamnosus GG was associated with better growth; it had no effect on colic/crying, or irritability, and it was associated with greater indexes of loose stools and a higher defecation frequency. Lactobacillus reuteri ATCC 55730 had no effect on growth, colic, crying, irritability, respiratory illness, antibiotic use, stool frequency, or stool consistency; however, it reduced the number of episodes of diarrhoea. L. reuteri DSM 17938 had no effect on growth, night-time sleeping, or flatulence, but it reduced the number of spitting episodes. Lactobacillus salivarius CEC5713 had no effect on growth, colic, crying, or irritability; however, it resulted in a significant reduction in the rate of diarrhoea and the number of episodes of respiratory symptoms. In conclusion, the administration of probiotic-supplemented formulae to healthy infants does not raise safety concerns with regard to growth and adverse effects. Some beneficial clinical effects are possible; however, there is no existing robust evidence to recommend their routine use. The latter conclusion may reflect the small amount of data on a specific probiotic strain(s) and outcomes, rather than a genuine lack of an effect.


European Journal of Pediatrics | 2015

Fermented infant formulas without live bacteria: a systematic review

Hania Szajewska; Agata Skórka; Małgorzata Pieścik-Lech

AbstractFermented formulas, i.e., those fermented with lactic acid-producing bacteria during the production process and not containing significant amounts of viable bacteria in the final product, are widely available in many countries. Our aim was to systematically review published evidence related to the safety and health effects of the administration of fermented infant formulas compared with standard infant formulas. The Cochrane Library, MEDLINE, and EMBASE databases and major pediatric conference proceedings were searched. Five randomized controlled trials (RCTs) involving 1326 infants met the inclusion criteria. Compared with standard formula, the use of fermented formula resulted in a similar weight gain and length gain during the study period. Data from one RCT, albeit large, suggest the effectiveness of fermented formula in preventing and treating acute diarrhea. Fermented formula has the potential to reduce some, albeit not well-defined, digestive symptoms. Current evidence does not support the use of fermented formula for preventing cow’s milk allergy. Conclusion: Limited available evidence suggests that the use of fermented infant formula, compared with the use of standard infant formula, does not offer clear additional benefits, although some benefit on gastrointestinal symptoms cannot be excluded.What is known• Fermented formulas, i.e., those fermented with lactic acid-producing bacteria during the production process and not containing significant amounts of viable bacteria in the final product, are widely available in many countries.What is new• Limited evidence available suggests that the use of fermented infant formula, compared with the use of standard infant formula, does not offer clear additional benefits, although some benefit on gastrointestinal symptoms cannot be excluded. At the same time, no negative health effects have been documented.


Acta Paediatrica | 2012

Efficacy and safety of a new apple-flavoured oral rehydration solution in children with acute gastroenteritis: a double-blind randomized controlled trial.

Małgorzata Pieścik-Lech; Henryk Szymański; Hania Szajewska

Aim:  To assess the efficacy and safety of a new oral rehydration solution (ORS) with improved flavour in the management of children with acute gastroenteritis (AGE).


Journal of Paediatrics and Child Health | 2017

Systematic review: Early infant feeding practices and the risk of wheat allergy

Anna Chmielewska; Małgorzata Pieścik-Lech; Raanan Shamir; Hania Szajewska

Wheat is a common allergen. Early feeding practices (breastfeeding, potentially allergenic foods) might affect the risk of allergy. To systematically evaluate the association between early feeding practices and the risk of wheat allergy and sensitisation.


European Journal of Pediatrics | 2013

Lactobacillus GG (LGG) and smectite versus LGG alone for acute gastroenteritis: a double-blind, randomized controlled trial

Małgorzata Pieścik-Lech; Magdalena Urbańska; Hania Szajewska


British Journal of Nutrition | 2016

Effects of prenatal and/or postnatal supplementation with iron, PUFA or folic acid on neurodevelopment: update.

Anna Chmielewska; Piotr Dziechciarz; Dorota Gieruszczak-Białek; Andrea Horvath; Małgorzata Pieścik-Lech; Marek Ruszczyński; Agata Skórka; Hania Szajewska


British Journal of Nutrition | 2018

Infant formulae supplemented with prebiotics: Are they better than unsupplemented formulae? An updated systematic review

Agata Skórka; Małgorzata Pieścik-Lech; Maciej Kołodziej; Hania Szajewska

Collaboration


Dive into the Małgorzata Pieścik-Lech's collaboration.

Top Co-Authors

Avatar

Hania Szajewska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Agata Skórka

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Anna Chmielewska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Szajewska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maciej Kołodziej

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Andrea Horvath

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Magdalena Urbańska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Marek Ruszczyński

Medical University of Warsaw

View shared research outputs
Researchain Logo
Decentralizing Knowledge